Name /AnHorn Medicines Co., Ltd.
Address /National Biotechnology Research Park C522, No. 99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei 115, Taiwan (R.O.C.)
Name /Chih Ming Chen
Title /Vice President of Biology
Telephone /(Work) 02-2786-2568 #161
AnHorn Medicines is a novel drug discovery company with a strong pipeline, offering therapies that Target and Degrade disease-causing proteins. Our mission is to develop new class of BIGPRO® (Bi-functional liGand induced PROteolysis) drugs under the foundation of Targeted Protein Degradation (TPD), to address a broad range of life-threatening and life-impairing diseases.
AnHorn Medicines focus on novel therapies for cancer, neurodegeneration, and aging diseases by applying AnHorn’s proprietary AIMCADD® platform. We are turning innovation into new therapeutics – new opportunities to target difficult-to-treat and drug resisting diseases.
AnHorn’s Drug Development Strategy:
Name /Wendy Lin
Phone /02-2786-2568 #166